The case for licensing cytosine now for smoking cessation is overwhelming.
King's College London, Institute of Psychiatry, London SE5 8AF, UK.
John A
JA
Stapleton
D000470:Alkaloids / Q000494:pharmacology*; D006801:Humans; D009538:Nicotine / Q000037:antagonists & inhibitors*; D016540:Smoking Cessation / Q000379:methods*; D061485:Tobacco Use Cessation Devices
D000470:Alkaloids; D009538:Nicotine